All posts tagged
Which EU Immuno-Oncology Company are you Cheering for?
The Most Important Battle in Gene Editing: CRISPR versus TALEN
How is Biotech Transforming Pharma’s R&D Model?
“In the Coming Decade, Off-the-Shelf Cell Therapy will Become a Reality”
What are the Best Countries to Recruit Biotech Talents in 2017?
CAR-T Competition Heats Up with a New IND Approval
A Cure for Cancer? How CAR-T Therapy is Revolutionizing Oncology
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
UPDATE: The First Off-the-Shelf CAR-T Cancer Therapy gets ready for Clinical Trials
UPDATE: The 5 Hottest European Biotechs in 2017 according to JP Morgan
The 10 Biggest Clinical Success Stories of 2016 in European Biotech
What do the CAR-T Patient Deaths Mean for the Future of the Field?
Labiotech UG, All Rights Reserved -
Send this to friend